U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 16, 2010
ADA-ES, INC.
(Name of registrant as specified in its charter)
Colorado | 000-50216 | 84-1457385 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
8100 SouthPark Way, Unit B, Littleton, Colorado | 80120 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (303) 734-1727
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 | Regulation FD Disclosure. |
On November 16, 2010, ADA-ES will present at the Ingalls & Snyder Specialty Chemicals Seminar in New York, NY. A copy of the presentation materials is attached hereto as an exhibit 99.1.
Item 9.01. | Financial Statements and Exhibits |
(d) The following items are furnished as exhibits to this report:
99.1 Ingalls & Snyder Specialty Chemicals Seminar presentation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: November 16, 2010
ADA-ES, Inc. Registrant |
/s/ MARK H. MCKINNIES |
Mark H. McKinnies |
Senior Vice President and Chief Financial Officer |
INDEX TO EXHIBITS
Exhibit No. |
Description | |
99.1 |
Ingalls & Snyder Specialty Chemicals Seminar presentation. |